Redo surgical aortic valve replacement for bioprosthetic structural valve deterioration
European Journal of Cardio-Thoracic Surgery · 2024
DOI: 10.1093/ejcts/ezae353 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2024. Verfasst von Matthias Raschpichler und 9 weiteren Autor:innen. Beteiligte Einrichtung: Leipzig Heart Center, University Clinic of Cardiac Surgery, University of Leipzig, Leipzig, Germany. Hauptthemen laut MEDLINE: Bioprosthesis, Reoperation, Aortic Valve, Heart Valve Prosthesis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES To compare isolated primary bioprosthetic surgical aortic valve replacement (SAVR) with isolated redo surgical aortic valve replacement (rSAVR) due to structural valve deterioration (SVD). METHODS Clinical data of consecutive patients who underwent primary isolated SAVR and isolated rSAVR due to SVD between 1 January 2011 and 31 December 2022, at Leipzig Heart Center were retrospectively compared with regard to the primary outcome of all-cause mortality or stroke during hospitalization. Secondary outcomes of interest included myocardial infarction, re-exploration for bleeding, and permanent pacemaker implantation. RESULTS A total of 2620 patients, 39.5% females, with a median EuroSCORE II of 1.7 [interquartile range (IQR) 1.1–2.7] were identified, of which rSAVR was performed in 174 patients (6.6%). Patients undergoing primary SAVR were older (69 vs 67 years of age, P = 0.001) and were less likely to have a history of prior stroke (0.9% vs 4.0%, P = 0.003). Although both all-cause death and death or stroke occurred less often following primary SAVR (0.5% vs 5.8%, and 2.2% vs 6.9%, respectively; P < 0.001), prior surgery was not associated with adverse clinical outcome in multivariable analysis. In a matched comparison of 322 patients, rates of death or stroke did not differ between groups (4.8% for both rSAVR and SAVR, P = 1.0). CONCLUSIONS Although redo surgery for SVD is associated with increased rates of early mortality and stroke by univariate analysis, much of this increased risk can be accounted for by comorbidities. Patients undergoing rSAVR on an elective basis can expect an outcome similar to that of primary SAVR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Leipzig Heart Center, University Clinic of Cardiac Surgery, University of Leipzig, Leipzig, Germany.
- Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Sydney, Australia.
- Sydney Medical School, University of Sydney, Australia.
ORCID-Profile: Matthias Raschpichler, Michael A Borger
Zitieren
APA
Raschpichler, M., Kiefer, P., Otto, W., Noack, T., Gerber, M., De Waha, S., Dashkevich, A., Leontyev, S., Misfeld, M., & Borger, M. A. (2024). Redo surgical aortic valve replacement for bioprosthetic structural valve deterioration. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezae353
Vancouver
Raschpichler M, Kiefer P, Otto W, Noack T, Gerber M, De Waha S, et al. Redo surgical aortic valve replacement for bioprosthetic structural valve deterioration. European Journal of Cardio-Thoracic Surgery. 2024. doi:10.1093/ejcts/ezae353
BibTeX
@article{Raschpichler2024,
author = {Raschpichler, Matthias and Kiefer, Philip and Otto, Wolfgang and Noack, Thilo and Gerber, Maria and De Waha, Suzanne and Dashkevich, Alexey and Leontyev, Sergey and Misfeld, Martin and Borger, Michael A},
title = {Redo surgical aortic valve replacement for bioprosthetic structural valve deterioration},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2024},
doi = {10.1093/ejcts/ezae353}
}
EUVIMED